C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations | NEJM

Prepare to become a physician, build your knowledge, lead a health care organization, and advance your career with NEJM Group information and services. Stay connected to what's important in medical research and clinical practice Subscribe to the most trusted and influential source ofmedical knowledge Already a subscriber? Renew or Sign in SUBSCRIBE OR RENEW Selected specialties View all specialties Selected Topics View all topics Selected Multimedia View all multimedia Current Issue Recent Issues Browse full issue index Recently Published Articles Browse recently published View all learning/CME Other NEJM Group Learning Subscribe or Renew ORIGINAL ARTICLE July 11, 2019N Engl J Med 2019; 381:111-120 DOI: 10.1056/NEJMoa1803185Chinese Translation 中文翻译 Metrics Point-of-care testing of C-reactive protein (CRP) may be a way to reduce unnecessary use of antibiotics without harming patients who have acute exacerbations of chronic obs

Prepare to become a physician, build your knowledge, lead a health care organization, and advance your career with NEJM Group information and services. Stay connected to what's important in medical research and clinical practice Subscribe to the most trusted and influential source ofmedical knowledge Already a subscriber? Renew or Sign in SUBSCRIBE OR RENEW Selected specialties View all specialties Selected Topics View all topics Selected Multimedia View all multimedia Current Issue Recent Issues Browse full issue index Recently Published Articles Browse recently published View all learning/CM